Bare Financial Services’s Avidity Biosciences RNAM Stock Holding History

Bare Financial Services’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37	Closed	-$2.67K	–	1861
2025 Q4	$2.67K	Sell	37 -2	-5%	-$129	﹤0.01%	765
2025 Q3	$1.7K	Buy	+39	New	+$1.58K	﹤0.01%	853

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Bare Financial Services's RNAM Position: Q1 2026 in Review

Bare Financial Services sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 37 shares — an estimated $2.67K sold.

Bare Financial Services first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $2.67K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Bare Financial Services reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Bare Financial Services sold 37 Avidity Biosciences shares in Q1 2026, an estimated $2.67K.
Bare Financial Services first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Bare Financial Services's Avidity Biosciences position peaked at $2.67K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.